Dmitry Sandler, DPM
Primary Podiatric Medicine · Hialeah, FLNPI 1588753040
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,300 of the $10,809 with a category attached, or 76.8%. It is spread thinly across 37 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,806 and has fallen 53.7% since, to $1,762 in 2025. Among primary podiatric medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $76.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$1K
- Paragon 28, Inc.$1K
- Treace Medical Concepts, Inc.$1K
- Orthofix Medical, Inc.$1K
- Organogenesis Inc.$788
- Stryker$689
- plus $4K from 31 others
Across 7 payments — averaging $11,574 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$50K
- Osiris Therapeutics Inc.$31K
What the payments were for
- Speaking & faculty fees$1251%
- Travel & lodging$2,33622%
- Food & beverage$8,30077%
- Education$490%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 21 | $1,465 |
| Paragon 28, Inc. | 4 | $1,424 |
| Treace Medical Concepts, Inc. | 8 | $1,285 |
| Orthofix Medical, Inc. | 12 | $1,212 |
| Organogenesis Inc. | 14 | $788 |
| Stryker(2 entities) | 8 | $689 |
| Ossio Inc | 2 | $526 |
| AbbVie | 21 | $485 |
| Osiris Therapeutics Inc. | 8 | $399 |
| Linvatec Corporation | 2 | $297 |
| Bioventus LLC | 3 | $266 |
| Kowa Pharmaceuticals America, Inc. | 9 | $156 |
| Johnson & Johnson | 2 | $149 |
| Biotissue Holdings Inc. | 2 | $148 |
| Bone Support Inc. | 1 | $141 |
| Biocomposites Inc | 1 | $136 |
| Zimmer Biomet | 3 | $135 |
| Restor3d, Inc. | 1 | $130 |
| Medtronic | 1 | $127 |
| AstraZeneca | 1 | $125 |
| Heron Therapeutics, Inc. | 1 | $122 |
| Nevro Corp. | 1 | $121 |
| Nalu Medical, Inc. | 1 | $102 |
| Solventum Corporation | 2 | $82 |
| Novastep Inc. | 1 | $49 |
| Aroa Biosurgery Incorporated | 1 | $32 |
| Checkpoint Surgical, Inc | 1 | $26 |
| EBI, LLC | 1 | $25 |
| Highridge Medical LLC | 1 | $25 |
| Acell, Inc. | 1 | $25 |
| Kerecis Limited | 1 | $23 |
| Merck | 1 | $19 |
| Abbott | 1 | $17 |
| Embody, Inc. | 1 | $17 |
| Zimvie Inc. | 1 | $15 |
| Acera Surgical, Inc. | 1 | $15 |
| Mimedx Group, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$1,323
- Stravix$992
- TrueLok Ring Fixation System$806
- TL-HEX$806
- Lapiplasty$797
- Grafix$731
- GrafixPL$731
- GRAFIX PL$261
- BioBrace 23mm$163
- PURAPLY WOUND MATRIX$144
- NeXus$143
- CERAMENTBONE VOID FILLER$141
- CERAMENT G$141
- ANCHORAGE$139
- Stimulan$136
- QUANTUM$134
- COLINK 2$134
- IN2BONES USA$134
- VenaSeal$127
- LOKELMA$125
How this compares
$10,809 in reported general payments places this provider in the 90th percentile of 68 primary podiatric medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $83 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Hialeah
- Robert SnyderTamarac$623K
- Melissa VerdeLongwood$257K
- Kevin LapoffGreenacres$64K
- Beth PearceSt Augustine$27K
- Richard MercadoMiami$10K
- Gladys de LeonOrlando$8K
- Tanika HarlisPort Saint Lucie$6K
- Liana SeldinCoral Gables$4K
- Jasmine CruzBoynton Beach$4K
- Mousa BatehJacksonville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.